Peptide Synthesis Market Expanding At A USD 1,011.99 Million By 2026

Posted by Neha Bora on January 8th, 2020

San Francisco, 8 January 2020: The Report Peptide Synthesis Market Size, Share & Trends Analysis Report By Product (Equipment, Reagents & Consumables, and Other), Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), and Hybrid Technology), And Segment Forecasts, 2019 – 2026

The global peptide synthesis market size is expected to reach USD 1,011.99 million by 2026 growing at a CAGR of 13.0%, according to a new report by Grand View Research, Inc. Significant research and innovation targeted towards the development of peptide therapeutics is set to boost the market growth in the near future. Additionally, increasing advancements in the peptide synthesis technologies is expected to offer profitable opportunities for the companies operating in the market.

A surge in the demand for custom peptide synthesis has been observed in the recent years; several companies operating in this industry offer products and services associated with custom peptide synthesis. For instance, a UK based company namely, Almac Group offers peptide synthesis suitable for research use. Constantly growing demand and evolving market landscape for custom peptides is set to offer lucrative opportunities for the market growth. The suppliers are expanding their production capacity to suffice the increasing demand for high quality peptides across research and therapeutics areas.

Rising focus of the pharmaceutical companies towards the development of novel biologics and shifting the peptide drugs from the pipeline stage to commercial scale further strengthens the market growth. Increase in the number of research activities performed on exploring the potential of high-quality peptides and peptide libraries in the development of vaccines and biomarker discovery heavily contributes to the revenue generated by the global peptide synthesis market. Moreover, introduction of modified peptides (GMP peptides) that possess enhanced stability and pharmacokinetic properties in the market is expected to maintain the double-digit market growth throughout the forecast period.

Therapeutic peptide development has witnessed remarkable growth in the recent years, this is further driven by significant increase in the patient pool suffering from cardiovascular and metabolic diseases. This has propelled the discovery of bioactive peptides exponentially which further drives the market demand.

Access Research Report of Peptide Synthesis Market @ https://www.grandviewresearch.com/industry-analysis/peptide-synthesis-market

Further key findings from the study suggest:

• Reagents & consumables accounted for the highest revenue generated in 2018 and is anticipated to maintain this trend throughout the forecast period.
• Peptide synthesis equipment has registered fastest growth during the forecast period.
• Peptide synthesizers segment serves to be a major contributor to the revenue generated by equipment in the global market and is anticipated to grow at highest CAGR of 13.91% from 2019-2026 among other peptide synthesis equipment.
• Liquid phase peptide synthesis (LPPS) technology dominated the peptide synthesis market in 2018 and is expected to continue this dominance throughout the forecast period.
• Therapeutic peptide synthesis has garnered largest share in the market in 2018 and is anticipated to maintain this trend throughout the forecast period.
• North America region has generated highest revenue in 2018 and is expected to maintain this dominance throughout the forecast period; sufficient presence of skilled professionals along with the strong network of peptide synthesis manufacturers is attributive to this region’s dominance in the global market.
• APAC is expected to offer lucrative opportunities for the market expansion, attributed to rising focus on the development of peptide therapeutics.
• Large patient pool for cardiovascular and metabolic diseases in the APAC region has significantly contributed to the revenue generated, contributing to the highest CAGR registered during the forecast period.
• Some of the key market participants are Genscript Biotech, Merck KGaA, Bachem Holdings, Biotage, CEM Corporation, Thermo Fisher, and Novo Nordisk among others.

Grand View Research has segmented the global peptide synthesis market on the basis of product, technology, application, end-use, and region:

Peptide Synthesis Product Outlook (Revenue, USD Million, 2014 - 2026)

• Equipment
  • Peptide Synthesizers
  • Lyophilizers
  • Chromatography Equipment
  • Others
• Reagents & Consumables
• Other

Peptide Synthesis Technology Outlook (Revenue, USD Million, 2014 - 2026)

• Solid Phase Peptide Synthesis (SPPS)
• Liquid Phase Peptide Synthesis (LPPS)
• Hybrid Technology

Peptide Synthesis Application Outlook (Revenue, USD Million, 2014 - 2026)

• Therapeutics
  • Cancer
  • Metabolic
  • Cardiovascular Disorder
  • Respiratory
  • GIT (Gastrointestinal Disorders)
  • Infectious Diseases
  • Pain
  • Dermatology
  • CNS
  • Renal
  • Others
• Diagnosis
• Research

Peptide Synthesis End-use Outlook (Revenue, USD Million, 2014 - 2026)

• Pharmaceutical & Biotechnology Companies
• Contract Development & Manufacturing Organization/Contract Research Organization
• Academic & Research Institutes

Peptide Synthesis Regional Outlook (Revenue, USD Million, 2014 - 2026)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA